Skip to Navigation | Skip to Main Content | Skip to Site Map | Mobile Site

Senate Tracker: Sign Up | Login

The Florida Senate

Practice of Pharmacy

by Health and Human Services Committee; Health Quality Subcommittee; and Rep. Peters and others (CS/CS/SB 1180 by Regulated Industries Committee; Health Policy Committee; and Senators Latvala, Soto, and Diaz de la Portilla)

This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.

Prepared by: Health Policy Committee (HP)

The bill amends ch. 465, F.S., the Florida Pharmacy Act (the act), to provide that the act and rules adopted under the act do not prohibit a Florida-licensed veterinarian from administering a compounded drug to any animal under the veterinarian’s care or dispensing a compounded drug to the animal’s owner or caretaker. The bill clarifies that this provision does not affect the regulation of the practice of pharmacy.

The bill also creates s. 465.1862, F.S., to require certain provisions in a contract between a pharmacy benefits manager and a pharmacy. A pharmacy benefits manager is an entity which contracts to administer or manage prescription drug benefits on behalf of a health insurance plan. The contract must require the pharmacy benefits manager to update maximum allowable cost pricing information at least every seven calendar days and to maintain a process that will eliminate drugs from maximum allowable costs list or modify drug prices to remain consistent with changes in pricing data and product availability on a timely basis. Maximum allowable cost is defined as the per-unit amount that a pharmacy benefits manager reimburses a pharmacist for a prescription drug, excluding dispensing fees, and prior to any copayments, coinsurances, and other cost-sharing charges.

If approved by the Governor, these provisions take effect July 1, 2015.

Vote: Senate 38-0; House 118-0